Phase 2
N=49
Smoking Cessation Intervention for Thoracic Patients
Lung Cancer
Bottom Line
View on ClinicalTrials.gov: NCT00580398 ↗Enrolled (actual)
49
Serious AEs
2.0%
Results posted
Nov 2014
Primary outcome: Primary: Determination of the Feasibility of a Cognitive Behavioral Smoking Cessation Intervention. — 17; 32 participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Smoking cessation counseling (Behavioral); varenicline (Drug)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Massachusetts General Hospital
- Primary completion
- Apr 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Determination of the Feasibility of a Cognitive Behavioral Smoking Cessation Intervention. |
17; 32 | — |
| SECONDARY Biochemically-validated 7-day Point Prevalence Tobacco Abstinence |
2; 11 | — |
Summary
The primary aim of the proposed study is to develop and assess the feasibility of delivering a smoking cessation intervention to patients undergoing lung surgery that begins before surgery and continues up to 3 months post-discharge. The secondary aim is to assess smoking cessation rates 3 months following surgery.
Eligibility Criteria
Inclusion Criteria
A patient is eligible if he/she:
- Is scheduled for a lung resection surgery with either a lung cancer diagnosis or a potential lung cancer diagnosis
- Smoked a cigarette in the past 2 weeks
- Is willing to make a pre-surgical quit attempt
Exclusion Criteria
Patients will be excluded from the intervention group if they are:
- Non-English speaking
- Determined medically ineligible by their surgeon
- Suffering from psychosis or dementia
- Have been taking Varenicline for longer than three weeks
- Have been taking Bupropion (for smoking cessation purposes) for more than three weeks
- Is otherwise unable to participate in the intervention.
Data sourced from ClinicalTrials.gov (NCT00580398). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.